Literature DB >> 1706812

Omega-conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: consequences for hemodynamics and autonomic reflexes in conscious rabbits.

D Pruneau1, J A Angus.   

Abstract

We investigated the effects of the N-type calcium channel blocking agent, omega-conotoxin GVIA, on the resting hemodynamics and on some autonomic reflexes in the conscious rabbit. omega-Conotoxin 3 and 10 micrograms/kg i.v. reduced mean arterial blood pressure by 16 +/- 2 and 25 +/- 3 mm Hg, respectively, over 30 min accompanied by a tachycardia. Renal vascular conductance (Doppler flowmeter) increased by 27.6 +/- 3.7 and 38.6 +/- 10.3% at 30 min after omega-conotoxin 3 and 10 micrograms/kg, respectively. Vasodilatation was also observed but to a lesser extent in the hindquarter and mesenteric vascular beds. The baroreceptor-heart rate reflex was evoked by a drug method (bolus injection of sodium nitroprusside and phenylephrine) and by inflation of perivascular balloons implanted on the thoracic vena cava and aorta. omega-Conotoxin (3 micrograms/kg) abolished the sympathetic component of the cardiac baroreceptor reflex without affecting vagal efferent activity. In addition, marked vagal-mediated bradycardia from (a) the "Bezold-Jarisch-like" reflex evoked by serotonin (1-10 micrograms/kg i.v.) and (b) the nasopharyngeal reflex evoked by cigarette smoke were unaffected by omega-conotoxin (3-10 micrograms/kg). We conclude that omega-conotoxin-induced N-type calcium channel blockade abolishes sympathetic but not vagal cardiac efferent activity. The hypotension and peripheral vasodilatation are probably due to the prejunctional sympatholytic action of the peptide. These N-type calcium channels are thus limited to the sympathetic varicosities in the rabbit.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706812     DOI: 10.1097/00005344-199010000-00022

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays.

Authors:  C E Wright; A D Robertson; S L Whorlow; J A Angus
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.

Authors:  C E Wright; J A Angus
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

3.  Role of N-type calcium channels in autonomic neurotransmission in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Human Dickkopf-1 (huDKK1) protein: characterization of glycosylation and determination of disulfide linkages in the two cysteine-rich domains.

Authors:  Mitsuru Haniu; Tom Horan; Chris Spahr; John Hui; Wei Fan; Ching Chen; William G Richards; Hsieng S Lu
Journal:  Protein Sci       Date:  2011-09-27       Impact factor: 6.725

5.  Effect of calcium antagonists (omega-conotoxin GVIA, verapamil, gallopamil, diltiazem) on bronchial smooth muscle contractions induced by soman.

Authors:  P Walday; E Fyllingen; P Aas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Analgesic effect of highly reversible ω-conotoxin FVIA on N type Ca2+ channels.

Authors:  Seungkyu Lee; Yoonji Kim; Seung Keun Back; Hee-Woo Choi; Ju Yeon Lee; Hyun Ho Jung; Jae Ha Ryu; Hong-Won Suh; Heung Sik Na; Hyun Jeong Kim; Hyewhon Rhim; Jae Il Kim
Journal:  Mol Pain       Date:  2010-12-21       Impact factor: 3.395

7.  Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration.

Authors:  Mahsa Sadeghi; Swetha S Murali; Richard J Lewis; Paul F Alewood; Sarasa Mohammadi; MacDonald J Christie
Journal:  Mol Pain       Date:  2013-10-20       Impact factor: 3.395

8.  Voltage-gated calcium channel antagonists and traumatic brain injury.

Authors:  Gene Gurkoff; Kiarash Shahlaie; Bruce Lyeth; Robert Berman
Journal:  Pharmaceuticals (Basel)       Date:  2013-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.